Institutional investors

A major player in private equity and infrastructure

15 years’ experience servicing institutional investors

  • A range of FPCI funds (French commingled fund structure) and expertise in dedicated mandates for major European institutional investors
  • Extensive coverage of all aspects of private equity
  • Stable, first-rate performance

Differentiated deal flow

  • Over 1,000 qualified projects reviewed per year
  • Regional opportunities seized ahead of the market thanks to the team’s personal network of contacts and its historical ties to the Crédit Agricole Group
  • Strong regional roots giving it first-class access to primary transactions

A personalised relationship and active support

  • Integrated support teams offering best-in-class services
  • Close relationship with investors
  • A dedicated client access on the corporate website
Expertises
Omnes Capital supports companies at every stage of their growth, from start-ups to mature businesses
NewsRoom
Press release
09 May 2019
Camerus Group accelerates its growth strategy by acquiring Lign'Expo and completing an LBO with Bpifrance and Siparex Mezzanine, backed by Omnes, its existing investor

Camerus Group accelerates its growth strategy by acquiring Lign'Expo and completing an LBO with Bpifrance and Siparex Mezzanine, backed by Omnes, its existing investor
Press release
09 May 2019
360 onlineprint enters British market after attracting an investment of 20.4 million dollars
360 onlineprint enters British market after attracting an investment of 20.4 million dollars
Publication
Omnes’ Environmental, Social and Governance (ESG) commitments
Press release
11 April 2019
NH TherAguix, a start-up specializing in nanomedicine for cancer radiotherapy, announces a €13 million round of fundraising, led by Bpifrance

NH TherAguix, a start-up specializing in nanomedicine for cancer radiotherapy, announces a €13 million round of fundraising, led by Bpifrance
Press release
09 April 2019
Appointments within Omnes: Omnes welcomes five newcomers as Director, Principal, Analyst, Middle Office Managers, and promotes four Principals
Appointments within Omnes: Omnes welcomes five newcomers as Director, Principal, Analyst, Middle Office Managers, and promotes four Principals
Press release
03 April 2019
AgomAb Therapeutics Completes Euros 21m Series A Financing
AgomAb Therapeutics Completes Euros 21m Series A Financing

Pages